XML 132 R101.htm IDEA: XBRL DOCUMENT v2.4.0.8
Schedule I - Condensed Financial Information of Registrant (Condensed Statements of Operations) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Revenues                      
Net investment income (loss)                 $ 69,613 $ 82,434 $ 74,161
Administrative service fees                 34,791 17,968 11,523
Divested operations and services revenue                 0 40,471 34,446
Total revenues 2,743,200 2,775,000 [1] 2,738,400 2,797,000 [2] 2,837,800 [3] 2,779,600 2,841,300 2,830,400 11,053,743 11,289,092 11,415,436
Expenses                      
General and administrative                 1,083,694 939,940 1,052,458
Depreciation and amortization                 38,589 31,146 31,152
Interest                 32,614 33,220 32,131
Divested operations and services expenses                 0 85,824 163,546
Total expenses                 10,783,790 11,257,442 11,253,672
Income (loss) from operations before income taxes 28,000 108,600 52,000 [4] 81,300 8,400 29,400 7,400 (13,600) 269,953 31,650 161,764
Income tax benefit                 (99,827) (5,969) (100,708)
Net income 19,800 66,800 [1] 33,500 50,100 [2] 6,000 [3],[5] 18,000 [6] 124,600 [7] (26,600) [8] 170,126 122,063 72,120
Parent Company [Member]
                     
Revenues                      
Net investment income (loss)                 1,316 1,459 493
Other Income                 229 204 690
Administrative service fees                 464,393 478,037 493,637
Divested operations and services revenue                 0 0 33,377
Total revenues                 465,938 479,700 528,197
Expenses                      
General and administrative                 431,354 470,156 649,524
Depreciation and amortization                 36,185 30,408 33,061
Interest                 33,589 35,112 34,456
Divested operations and services expenses                 0 0 33,377
Total expenses                 501,128 535,676 750,418
Income (loss) from operations before income taxes                 (35,190) (55,976) (222,221)
Income tax benefit                 13,014 5,633 132,690
Equity in net income (loss) of subsidiaries                 192,302 172,406 161,651
Net income                 $ 170,126 $ 122,063 $ 72,120
[1] Includes $32.1 million of Medicaid premium revenue as a result of Medicaid/Medi-Cal retroactive rate adjustments for periods prior to 2013.
[2] Includes $42.2 million of Medicaid premium revenue as a result of Medicaid/Medi-Cal retroactive rate adjustments related to 2011 and 2012.
[3] Includes $31.5 million of premium revenue as a result of Medicaid/Medi-Cal retroactive rate adjustment related to the third quarter of 2012 and prior periods.
[4] Includes a $12.9 million in pretax costs related to continuing efforts to address scale issues.
[5] Includes a $2.2 million unfavorable adjustment to the gain on sale of discontinued operation, an $8.2 million expense related to our G&A cost reduction efforts, a $5.0 million expense related to the early termination of a medical management contract and $7.1 million of litigation-related expenses.
[6] Includes a $2.4 million unfavorable adjustment to the gain on sale of discontinued operation and a $7.2 million expense related to our G&A cost reduction efforts.
[7] Includes $119.4 million gain on sale of discontinued operation related to the sale of our Medicare PDP business to CVS Caremark. Also includes $7.9 million of adverse development related to prior years recorded as part of health care costs, and a $10.8 million expense related to our G&A cost reduction efforts.
[8] Includes $25.0 million of adverse development related to prior periods recorded as part of health care costs, a $9.5 million expense related to our G&A cost reduction efforts and an unfavorable $0.7 million in pretax litigation reserve adjustment. Also includes a $6.5 million insurance reimbursement related to a prior legal settlement.